Collectively, we showed that dysregulated miR-371b-5p/CSDE1/RAC1 axis deepens tumor progression and aggressiveness in patients with TNBC and suggested that miR-371b-5p is a potential prognostic biomarker for TNBC. This evidence concerns the gene CSDE1 and neoplasm.